Gastroenterology Clinical Trials
Doylestown Health's gastroenterology team participates in clinical trials and research to help shape the way gastrointestinal disease is treated.
Active Trials: Open to Enrollment
Non-alcoholic Stearotic Hepatitis (NASH, fatty liver) - REGENERATE (NASH)
- Evaluating the impact on NASH with fibrosis of obeticholic acid treatment
- Coordinated by the Doylestown Health Medical Research Department: 215.345.2119
Active Trials: Not Accepting New Patients
Moderate to severe Ulcerative Colitis - UNIFI
- Evaluating the safety and efficacy of ustekinumab induction and maintenance therapy in participants with moderately to severely active ulcerative colitis
- Enrolled patients in follow up through February 2020
For more information about Doylestown Health's open trials, visit the U.S. National Institutes of Health's Clinical Trials database.